Handelsavisen
prelaunch
Companies Financials HIPO.K
HI
HIPO.K NYSE Insurance

Hipo.K

$30,29
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
778,4M USD
P/E
6,9x
EV / Rev
Div yield
Op margin
ROE
13,2 %
Net margin
12,3 %
Debt / equity
Beta
52w range
Volume
Day range
Prev close
$30,29
Open
Next earnings
2026-10-28
Ex-dividend
TR 1Y
About

HIPO.K operates as a multiline insurance and broker within the Financials sector, generating revenue through insurance premiums and brokerage activities.

Business. HIPO.K operates as a multiline insurance and broker within the Financials sector, generating revenue through insurance premiums and brokerage activities.

Classification85 %
SectorFinancials
Industry groupInsurance
Generated · model-assisted
Sell-side consensus
BUY6 analysts
4 buy2 hold0 sell
Avg 12m price target41,20

Analyst recommendations

6 analysts · consensus Buy
Buy4
Hold2
Sell0
12-month price target
41,20
Consensus of sell-side coverage.
Upcoming events
  • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
6,9x
P/E
Analysts
Buy
6 analysts · indicative
Ownership
Dimensional Fund Advisors, L.P.
largest disclosed fund holder
Profitability
13,2 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning HIPO.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,7 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,4 %−2,7 %−0,9 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Consumer Staples−0,7 %+2,3 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to HIPO.K. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ3 2026 earnings (expected)2026-10-28 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR
    • Congressional trades
    • CongressMarie Newman — Hippo Holdings Inc.2021-11-19 · IL · Purchase · $1,001 - $15,000

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    HIPO.K operates as a multiline insurance and broker within the Financials sector, generating revenue through insurance premiums and brokerage activities.

    Classification85 %
    SectorFinancials
    Industry groupInsurance
    AI synthesis
    GENERATED

    HIPO.K maintains a conservative capital structure with a debt-to-equity ratio of 0.0, indicating no interest-bearing debt on the balance sheet. The company holds $218.3 million in cash and equivalents against total liabilities of $1,469.4 million, resulting in a low liquidity risk assessment. With a market capitalization of $778.4 million and a price-to-book ratio of 1.79, the equity is valued at a premium to its book value of $436.1 million. The current ratio is not explicitly provided, but the absence of debt and significant cash holdings suggest adequate short-term solvency.

    Profitability metrics show a return on equity (ROE) of 13.23% and a return on assets (ROA) of 3.03% for the latest period. The company generated $57.7 million in net income on $468.6 million in revenue, implying a net margin of approximately 12.3%. The price-to-earnings ratio stands at 13.49, suggesting the market prices the earnings at a moderate multiple. Without cohort median data provided in the input, direct comparative analysis against industry peers is omitted, but the positive ROE and ROA indicate efficient use of capital.

    Revenue concentration by segment or geography is not detailed in the available data. The company is classified as a multiline insurer and broker, implying a diversified product mix, but specific revenue breakdowns are absent. Consequently, concentration risk cannot be quantified from the provided segments or geography sections.

    Growth trajectory analysis is limited by the absence of historical period data in the input. The latest normalized period shows revenue of $468.6 million and net income of $57.7 million. Without prior year or quarterly trend data, year-over-year growth rates cannot be calculated. The operating cash flow of $9.2 million is significantly lower than net income, suggesting potential working capital adjustments or non-cash income items, while capital expenditure is negligible at $0.1 million.

    Risk assessment indicates low liquidity risk and low dilution risk. The key flags section reports no immediate filing-based liquidity or dilution concerns. The shares outstanding are identical for basic and diluted counts (25,699,704), confirming no current dilutive securities such as options or warrants are impacting the share count. The primary risk appears to be operational or market-related rather than structural financial distress.

    Recent observations include analyst estimates with a mean price target of $41.20 and a median of $43.00, representing a potential upside from the current market price of $30.29. The mean recommendation is 2.17, leaning towards a buy rating with 1 strong buy and 3 buy ratings versus 2 holds. News events indicate system reconciler activities for coverage closure, but no specific corporate actions or material news events are disclosed in the observations.

    Key takeaways
    • Debt-free balance sheet with $218.3 million in cash provides strong financial flexibility.
    • ROE of 13.23% and P/E of 13.49 suggest reasonable profitability relative to valuation.
    • Analyst consensus indicates upside potential with a mean target of $41.20 vs current $30.29.
    • No dilution risk identified as basic and diluted shares are identical.
    • Operating cash flow ($9.2M) is low relative to net income ($57.7M), warranting monitoring of cash conversion.

    Bull / Bear case

    analysis pipeline
    — missing data

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-04-30
    Q1 2026 · Quarter highlights
    Open report →

    Operating income +115,7% YoY; Net income +114,9% YoY.

    Revenue
    Operating income$7.2M+115,7 % YoY
    Net income$7.1M+114,9 % YoY
    Free cash flow$8.7M+120,4 % YoY
    EPS
    Operating cash flow$8.5M+123,9 % YoY
    Financials
    Income statement
    Revenue
    Gross profit
    Operating income$7.2M
    Net income$7.1M
    Balance sheet
    Total assets$2.06B
    Total liabilities$1.61B
    Total equity$448.7M
    Cash & equivalents$275.4M
    Long-term debt$47.9M
    Cash flow
    Operating cash flow$8.5M
    CapEx-$3.2M
    Free cash flow$8.7M
    SBC
    Highlights
    • Operating income +115,7% YoY
    • Net income +114,9% YoY
    • Free cash flow +120,4% YoY

    Valuation TTM

    Market price
    $30,29
    Market cap
    $778.4M
    Enterprise value
    $560.1M
    P/E
    6.9x
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    4.8x
    EV / OCF
    60.9x
    P / B
    1.8x
    P / Tangible book
    1.8x
    Tangible book
    $436.1M
    Net cash
    $218.3M
    Current ratio
    Debt / equity
    ROA
    3.0%
    ROE
    13.2%
    Cash conversion
    16.0%
    CapEx / revenue
    0.0%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    Business relationships21 disclosed relationships · 2 types · extracted from filings & disclosures
    Subsidiaries20
    EX21:0a198d02f841EX21:0a198d02f841Subsidiarie97%
    EX21:1c4f3520569eEX21:1c4f3520569eSubsidiarie97%
    EX21:39085dcc77d4EX21:39085dcc77d4Subsidiarie97%
    EX21:425c89ed5bb7EX21:425c89ed5bb7Subsidiarie97%
    EX21:4c937bbfe5b8EX21:4c937bbfe5b8Subsidiarie97%
    EX21:4d7c97ca9e20EX21:4d7c97ca9e20Subsidiarie97%
    EX21:57033161ddb2EX21:57033161ddb2Subsidiarie97%
    EX21:80828c5c6b2fEX21:80828c5c6b2fSubsidiarie97%
    EX21:8a4bba0e442fEX21:8a4bba0e442fSubsidiarie97%
    EX21:9cc3e484e4e5EX21:9cc3e484e4e5Subsidiarie97%
    EX21:aa0f7e80ff78EX21:aa0f7e80ff78Subsidiarie97%
    EX21:b1de190ba3f7EX21:b1de190ba3f7Subsidiarie97%
    EX21:b59266157a92EX21:b59266157a92Subsidiarie97%
    EX21:b5d7c8b6dfa3EX21:b5d7c8b6dfa3Subsidiarie97%
    EX21:bac9c5b273a3EX21:bac9c5b273a3Subsidiarie97%
    EX21:d6be7fb89a39EX21:d6be7fb89a39Subsidiarie97%
    EX21:db7fdf25ee36EX21:db7fdf25ee36Subsidiarie97%
    EX21:de01d14c85f1EX21:de01d14c85f1Subsidiarie97%
    EX21:e1ba252a33b5EX21:e1ba252a33b5Subsidiarie97%
    EX21:f753a4298dd2EX21:f753a4298dd2Subsidiarie97%

    Supply chain

    Vendors → HIPO ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSHIPOHIPOHipo.K21 entitiesBaldwin Insurance GrouInsuranceUS
    1 mention in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 33 %
    EPS
    Consensus EPS
    0,33
    Predicted surprise
    -0,03
    Beat probability
    33 %
    Analysts
    6
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-07-29 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate0,33
    Revenueno estimateno estimate569,5M USD
    Operating incomeno estimateno estimate11,5M USD
    Full-year consensus mean (period as reported by source) · consensus in USD. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution6 analysts
    Strong buy1
    Buy3
    Hold2
    Sell0
    Strong sell0
    12-month price target$41,20 · Median $43,00
    Low $33,00High $47,00
    Operating income · consensus11,5M USD
    EPS surprise
    +577,9 %
    reported vs consensus · beat
    Revenue surprise
    −17,7 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$33,00
    Mean$41,20
    Median$43,00
    High$47,00
    Spot$30,29
    +36.0 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Net Margin12,3 %Above median
    ROE13,2 %Above median
    Capex / Rev0,0 %Below median
    D/E0,00Above median
    Cash Conv0,16Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Reference data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    • Ev To Revenue
      enterprise_value / revenue
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Market Cap
      market_price * shares_outstanding_diluted
    Source documents
    • HIPPO HOLDINGS INC. Market data — financials · 2026-07-29
    • reconciler_enqueue (reconciler) on HIPO.K · 2026-07-29
    • Hippo Holdings Inc Market data — analyst estimates · 2026-07-29
    • Hippo Holdings Inc Market data — ESG · 2026-07-29
    • HIPO.K HA canonical relationships · 2026-07-29

    Ownership & reference

    Top holders

    • Dimensional Fund Advisors, L.P.Investment Managers · as of 2026-03-310,00 %$10M
    • Geode Capital Management, L.L.C.Investment Managers · as of 2026-03-310,00 %$15M
    • Charles Schwab Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$4M
    • Northern Trust Investments, Inc.Investment Managers · as of 2026-03-310,00 %$5M
    • American Century Investment Management, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • Vanguard Capital Management, LLCInvestment Managers · as of 2025-12-310,00 %$37M
    • BlackRock Institutional Trust Company, N.A.Investment Managers · as of 2024-06-300,00 %$22M
    • AQR Capital Management, LLCInvestment Managers · as of 2026-03-310,00 %$1M
    • Goldman Sachs Asset Management, L.P.Investment Managers · as of 2026-03-310,00 %$3M
    • Nuveen LLCInvestment Managers · as of 2024-12-310,00 %$1M
    • State Street Investment Management (US)Investment Managers · as of 2026-03-310,00 %$11M
    • Morgan Stanley Smith Barney LLCInvestment Managers · as of 2026-03-310,00 %$6M
    • Bank of New York Mellon CorpInstitutional Investor · as of 2026-03-310,00 %$2M
    • AMERIPRISE FINANCIAL INCInstitutional Investor · as of 2026-03-310,00 %$1M
    • LPL Financial LLCInvestment Managers · as of 2026-03-310,00 %$1M
    • AllianceBernstein L.P.Investment Managers · as of 2026-03-310,00 %$0M
    • JANUS HENDERSON GROUP PLCInstitutional Investor · as of 2026-03-310,00 %$0M
    • UBS Financial Services, Inc.Investment Managers · as of 2026-03-310,00 %$1M
    • T. Rowe Price Associates, Inc.Investment Managers · as of 2026-03-310,00 %$0M
    • Invesco QQQ TrustFunds · as of 2026-03-310,00 %$0M
    • Wells Fargo AdvisorsBrokerage Firms · as of 2026-03-310,00 %$0M
    • JONES FINANCIAL COMPANIES LLLPInstitutional Investor · as of 2026-03-310,00 %$0M
    • FMR LLCInstitutional Investor · as of 2026-03-310,00 %$0M
    • PNC Investments LLCInvestment Managers · as of 2026-03-310,00 %$0M

    Leadership

    • Assaf WandExecutive Chairman of the Board

    Insider activity

    Net selling0 buys · 7 sellsnet -$810K15 insiders · last 365d
    • Zeltser GuyChief Financial Officer · Common StockSold 1 669 @ $30,98$52K · 2026-07-28
    • McCathron RichardDirector, Chief Executive Officer · Common StockSold 5 000 @ $28,53$143K · 2026-07-09
    • Boettcher LauraChief Operating Officer · Common StockOther 11 674 · 2026-06-10
    • McCathron RichardDirector, Chief Executive Officer · Common StockSold 5 000 @ $25,00$125K · 2026-06-09
    • Ellis StewartDirector · Common StockOther 4 820 · 2026-06-03
    • Fouche Lori DickersonDirector · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
    • Fouche Lori DickersonDirector · Common StockOther 4 808 · 2026-06-02
    • WIJNBERG SANDRA SDirector · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
    • WIJNBERG SANDRA SDirector · Common StockOther 4 808 · 2026-06-02
    • Hay Laura JDirector · Common StockOther 2 502 @ $25,40$64K · 2026-06-02
    • Hay Laura JDirector · Common StockOther 4 808 · 2026-06-02
    • Holliday Susan ClaireDirector · Common StockOther 2 502 @ $25,40$64K · 2026-06-02
    • Holliday Susan ClaireDirector · Common StockOther 4 808 · 2026-06-02
    • NICHOLS JOHN DRAKEDirector · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
    • NICHOLS JOHN DRAKEDirector · Common StockOther 4 808 · 2026-06-02
    • Feder EricDirector · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
    • FRATER HUGH RDirector · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
    • FRATER HUGH RDirector · Common StockOther 4 808 · 2026-06-02
    • Schaaf MarkDirector · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
    • Schaaf MarkDirector · Common StockOther 4 808 · 2026-06-02
    • Landman SamDirector · Common StockOther 4 808 · 2026-06-02
    • Landman SamDirector · Common StockOther 4 738 @ $25,40$120K · 2026-06-02
    • Ostergaard TorbenCEO Spinnaker · Common StockOther 1 340 @ $26,41$35K · 2026-05-15
    • Stienstra MichaelGM & Chief Insurance, HHIP · Common StockOther 1 259 @ $26,41$33K · 2026-05-15
    • Ostergaard TorbenCEO Spinnaker · Common StockSold 3 667 @ $26,10$96K · 2026-05-15

    Short positioning

    887.1Kshares short+12.3% vs prior
    5.75days to cover
    48.4%short of daily vol
    247fails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    HIPO.KCanonical
    NYSE · USD

    Intel & risk

    PredictorBeat prob33 %Surprise-0,03Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.
    Relationship graph
    HIPOBWIN.OEX21:0a1EX21:1c4EX21:390EX21:425EX21:4c9EX21:4d7EX21:570EX21:808EX21:8a4Insurance
    This companySectorPartnersSubsidiaries

    Evidence & claims

    From filings & derived data
    • Operating cash flow (YoY) (2025-12-31 vs 2024-12-31): -80.6%Derived (calculated)
    • Capex (YoY) (2025-12-31 vs 2024-12-31): -66.7%Derived (calculated)
    • Debt-to-equity (FY 2025-12-31): 3.37xDerived (calculated)
    • Return on assets (FY 2025-12-31): 3.3%Derived (calculated)
    • Net margin (FY 2025-12-31): 13.4%Derived (calculated)
    • Return on equity (FY 2025-12-31): 14.4%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 10.5%Derived (calculated)
    • Total liabilities (YoY) (2025-12-31 vs 2024-12-31): 24.7%Derived (calculated)
    • EPS (basic) (YoY) (2025-12-31 vs 2024-12-31): 239.0%Derived (calculated)
    • Net income (YoY) (2025-12-31 vs 2024-12-31): 318.9%Derived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): 23.5%Derived (calculated)
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): 20.4%Derived (calculated)
    • Revenue (YoY) (2025-12-31 vs 2024-12-31): 25.9%Derived (calculated)
    • EPS (diluted) (YoY) (2025-12-31 vs 2024-12-31): 235.4%Derived (calculated)
    • Total liabilities (annual): USD 1.47BSEC XBRL filing
    • Cash & equivalents (annual): USD 218.3MSEC XBRL filing
    • Pre-tax income (annual): USD 63.3MSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES 2SEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES 2SEC XBRL filing
    • Capex (annual): USD 100KSEC XBRL filing
    • Shareholders' equity (annual): USD 436.1MSEC XBRL filing
    • Revenue (annual): USD 468.6MSEC XBRL filing
    • Net income (annual): USD 62.6MSEC XBRL filing
    • Operating cash flow (annual): USD 9.2MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-10-28EVENTUpcomingQ3 2026 earnings (expected) estimated date
    2026-07-30 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-28INSIDERZeltser Guy sold 1.7k sh — Chief Financial Officer ~$52k
    2026-07-09INSIDERMcCathron Richard sold 5.0k sh — Director, Chief Executive Officer ~$143k
    2026-06-15FILING8-K filing →
    2026-06-10 00:00 UTCINSIDER20 insider transactions — 2026-06 · net buy $845k
    2026-06-10 00:00 UTCINSIDER20 insider transactions — 2026-06 · net buy $845k
    2026-06-10INSIDERBoettcher Laura transacted 11.7k sh — Chief Operating Officer
    2026-06-09INSIDERMcCathron Richard sold 5.0k sh — Director, Chief Executive Officer ~$125k
    2026-06-05FILING8-K filing →
    2026-06-03INSIDEREllis Stewart transacted 4.8k sh — Director
    2026-06-02INSIDERFouche Lori Dickerson transacted 4.7k sh — Director ~$120k
    2026-06-02INSIDERFouche Lori Dickerson transacted 4.8k sh — Director
    2026-06-02INSIDERWIJNBERG SANDRA S transacted 4.7k sh — Director ~$120k
    2026-06-02INSIDERWIJNBERG SANDRA S transacted 4.8k sh — Director
    2026-06-02INSIDERHay Laura J transacted 2.5k sh — Director ~$64k
    2026-06-02INSIDERHay Laura J transacted 4.8k sh — Director
    2026-06-02INSIDERHolliday Susan Claire transacted 2.5k sh — Director ~$64k
    2026-06-02INSIDERHolliday Susan Claire transacted 4.8k sh — Director
    2026-06-02INSIDERNICHOLS JOHN DRAKE transacted 4.7k sh — Director ~$120k
    2026-06-02INSIDERNICHOLS JOHN DRAKE transacted 4.8k sh — Director
    2026-06-02INSIDERFeder Eric transacted 4.7k sh — Director ~$120k
    2026-06-02INSIDERFRATER HUGH R transacted 4.7k sh — Director ~$120k
    2026-06-02INSIDERFRATER HUGH R transacted 4.8k sh — Director
    2026-06-02INSIDERSchaaf Mark transacted 4.7k sh — Director ~$120k
    2026-06-02INSIDERSchaaf Mark transacted 4.8k sh — Director
    2026-06-02INSIDERLandman Sam transacted 4.8k sh — Director
    2026-06-02INSIDERLandman Sam transacted 4.7k sh — Director ~$120k
    2026-05-15 00:00 UTCINSIDER7 insider transactions — 2026-05 · net sell $625k
    2026-05-15 00:00 UTCINSIDER7 insider transactions — 2026-05 · net sell $625k
    2026-05-15INSIDEROstergaard Torben transacted 1.3k sh — CEO Spinnaker ~$35k
    2026-05-15INSIDERStienstra Michael transacted 1.3k sh — GM & Chief Insurance, HHIP ~$33k
    2026-05-15INSIDEROstergaard Torben sold 3.7k sh — CEO Spinnaker ~$96k
    2026-04-30 06:05 UTCEARNINGSQuarterly results — Q1 2026 Net USD 7.1M
    2026-04-30FILING10-Q filing →
    2026-04-30FILING8-K filing →
    2026-04-27 00:00 UTCINSIDER5 insider transactions — 2026-04 · net sell $265k
    2026-04-27 00:00 UTCINSIDER5 insider transactions — 2026-04 · net sell $265k
    2026-04-22FILINGDEF 14A filing →
    2026-03-09 00:00 UTCINSIDER1 insider transaction — 2026-03 · net sell $129k
    Showing the 40 most recent of 61 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Reference data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage